Estradiol Therapy
Recent Findings from E. Migoya and Co-Authors Highlight Research in Estradiol Therapy
Published in Drug Week, September 16th, 2011
2011 SEP 16 -- According to the authors of a study from Miami, Florida, "Sitagliptin is a dipeptidyl peptidase-IV (DPP-4) inhibitor used for the treatment of patients with type 2 diabetes mellitus. This randomized, placebo-controlled, 2-period, crossover study evaluated the effect of sitagliptin on the pharmacokinetics of 17 alpha-ethinyl estradiol (EE2) and norethindrone (NET) in healthy female subjects who were receiving oral contraceptives for > 3 months prior to enrollment."
"A total of 18 subjects with normal menstrual cycles received the oral contraceptive pill ORTHO-NOVUM ® 7/7/7 on days 1 to 28 for 2 successive cycles, and on days 1 to 21...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-09-16)
More Articles from Drug Week
- Laboratory Chemicals
Data from National Center for Scientific Research (CNRS) Provide New Insights into Laboratory Chemicals - Cardiovascular Research
Data on Cardiovascular Research Detailed by J.V. Bodkin and Co-Authors - General Chemical Research
Data on General Chemical Research Detailed by Researchers at Nanyang Technological University - Central Nervous System
Findings in Central Nervous System Reported from R.P. Clauss and Co-Researchers - Theoretical Chemistry
Findings in Theoretical Chemistry Reported from University of Kent - Cholesterol
Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
